Nuveen
SVRA icon

Nuveen’s Savara SVRA Stock Holding History

Nuveen’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Sell
339,319
-4,234
-1% -$22.7K ﹤0.01% 2555
2026
Q1 		$1.88M Buy
343,553
+70,951
+26% +$395K ﹤0.01% 2304
2025
Q4 		$1.64M Buy
272,602
+35,767
+15% +$175K ﹤0.01% 2373
2025
Q3 		$846K Sell
236,835
-83,438
-26% -$247K ﹤0.01% 2696
2025
Q2 		$730K Sell
320,273
-64,830
-17% -$176K ﹤0.01% 2746
2025
Q1 		$1.07M Buy
385,103
+324
+0.1% +$895 ﹤0.01% 2619
2024
Q4 		$1.18M Sell
384,779
-30,766
-7% -$107K ﹤0.01% 2639
2024
Q3 		$1.76M Buy
415,545
+56,294
+16% +$249K ﹤0.01% 2480
2024
Q2 		$1.45M Buy
359,251
+197,039
+121% +$877K ﹤0.01% 2546
2024
Q1 		$808K Hold
162,212
– – ﹤0.01% 2781
2023
Q4 		$762K Hold
162,212
– – ﹤0.01% 2845
2023
Q3 		$613K Buy
162,212
+17,877
+12% +$63.7K ﹤0.01% 2775
2023
Q2 		$461K Buy
+144,335
New +$339K ﹤0.01% 2935
2021
Q2 		– Sell
-154,027
Closed -$1.63M – 3526
2021
Q1 		$1.63M Buy
+154,027
New +$264K ﹤0.01% 2708

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Nuveen's SVRA Position: Q2 2026 in Review

Nuveen reduced its Savara (SVRA) stake by 1.2% in Q2 2026, selling an estimated $22.7K and leaving 339,319 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2555.

Nuveen first reported a position in SVRA in Q1 2021 and has held it in 14 quarters since. 181 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • Nuveen held 339,319 shares of Savara worth $2.09M as of Q2 2026.
  • Nuveen sold 4,234 Savara shares in Q2 2026, an estimated $22.7K.
  • Savara made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2555 holding.
  • Nuveen first reported a position in Savara in Q1 2021 and has held it in 14 quarters since.
  • 181 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.